title: Vitiligo is not a cosmetic disease.
authors.affiliation: University of Bordeaux and National Reference Center for Rare Skin Diseases and Hôpital St-André, Bordeaux, France. Electronic address: khaled.ezzedine@aphp.fr.
authors.forename: Khaled
authors.initials: K
authors.lastname: Ezzedine
authors.affiliation: Brigham and Women's Hospital, Boston, Massachusetts.
authors.forename: Vaneeta
authors.initials: V
authors.lastname: Sheth
authors.affiliation: Department of Dermatology, St Vincent's Hospital and Royal Children's Hospital, Skin and Cancer Foundation, Melbourne, Australia.
authors.forename: Michelle
authors.initials: M
authors.lastname: Rodrigues
authors.affiliation: Center of Evidence-Based Dermatology, University of Nottingham, Nottingham, United Kingdom.
authors.forename: Viktoria
authors.initials: V
authors.lastname: Eleftheriadou
authors.affiliation: Division of Dermatology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts.
authors.forename: John E
authors.initials: JE
authors.lastname: Harris
authors.affiliation: Multicultural Dermatology Center, Department of Dermatology, Henry Ford Hospital, Detroit, Michigan.
authors.forename: Iltefat H
authors.initials: IH
authors.lastname: Hamzavi
authors.affiliation: Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.
authors.forename: Amit G
authors.initials: AG
authors.lastname: Pandya
mesh_terms: D001327:Autoimmune Diseases / Q000145:classification* / Q000191:economics / Q000628:therapy; D006801:Humans; D019458:Insurance Coverage; D007348:Insurance, Health; D038801:International Classification of Diseases; D011788:Quality of Life; D014820:Vitiligo / Q000145:classification* / Q000191:economics / Q000276:immunology / Q000628:therapy
keywords: autoimmune disease; burden; cosmetic; insurance payers; patient-reported outcomes; quality of life; reimbursement; vitiligo